<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Autosomal recessive spinocerebellar ataxias (SCARs)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Autosomal recessive spinocerebellar ataxias (SCARs)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Autosomal recessive spinocerebellar ataxias (SCARs)</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="30%"></colgroup> <tbody> <tr> <td class="subtitle1">Disorder</td> <td class="subtitle1">Distinguishing features</td> <td class="subtitle1">Gene or locus</td> <td class="subtitle1">Protein</td> </tr> <tr> <td>SCAR1</td> <td>Now classified as SCAN2 (AOA2)</td> <td> </td> <td> </td> </tr> <tr> <td>SCAR2</td> <td>Ataxia, developmental delay</td> <td><em>PMPCA</em></td> <td>Alpha-mitochondrial processing peptidase, beta subunit</td> </tr> <tr> <td>SCAR3</td> <td>Ataxia, blindness, deafness</td> <td>6p21-23</td> <td> </td> </tr> <tr> <td>SCAR4</td> <td>Ataxia, saccadic intrusions, spasticity, hyperreflexia</td> <td><em>VPS13D</em></td> <td>Vacuolar protein sorting 13 homolog D</td> </tr> <tr> <td>Formerly SCAR5</td> <td>Galloway-Mowat syndrome 1 (nonprogressive congenital cerebellar ataxia, infantile-onset microcephaly, central nervous system abnormalities)</td> <td><em>WDR73</em></td> <td>WD repeat domain 73</td> </tr> <tr> <td>SCAR6</td> <td>Nonprogressive infantile cerebellar ataxia, delayed walking and speech, hypotonia, clumsy movements</td> <td>20q11-13</td> <td> </td> </tr> <tr> <td>SCAR7</td> <td>Ataxia, eye movement difficulties</td> <td><em>TPP1</em></td> <td>Tripeptidyl peptidase 1</td> </tr> <tr> <td>SCAR8</td> <td>Progressive ataxia, neurodegeneration, spasticity</td> <td><em>SYNE1</em></td> <td>Nesprin-1</td> </tr> <tr> <td>SCAR9/COQ10D4</td> <td>Childhood-onset cerebellar ataxia, exercise intolerance, coenzyme Q10 deficiency</td> <td><em>ADCK1</em></td> <td>AarF domain containing kinase 1</td> </tr> <tr> <td>SCAR10</td> <td>Ataxia, dysarthria, nystagmus, marked cerebellar atrophy, coenzyme Q10 deficiency</td> <td><em>ANO10</em></td> <td>Anoctamin 10</td> </tr> <tr> <td>SCAR11</td> <td>Ataxia, developmental delay, dysarthria</td> <td><em>SYT14</em></td> <td>Synaptotagmin 14</td> </tr> <tr> <td>SCAR12</td> <td>Ataxia, generalized seizures in infancy, developmental delay</td> <td><em>WWOX</em></td> <td>WW domain containing oxidoreductase</td> </tr> <tr> <td>SCAR13</td> <td>Ataxia, delayed intellectual development, poor/absent speech, hyperreflexia</td> <td><em>GRM1</em></td> <td>Glutamate metabotropic receptor 1</td> </tr> <tr> <td>SCAR14</td> <td>Early-onset gait ataxia, developmental delay, eye movement abnormalities</td> <td><em>SPTBN2</em></td> <td>Spectrin beta, non-erythrocytic 2</td> </tr> <tr> <td>SCAR15</td> <td>Early-onset ataxia, cognitive impairment, dysarthria</td> <td><em>RUBCN</em></td> <td>RUN and cysteine rich domain containing Beclin 1 interacting protein</td> </tr> <tr> <td>SCAR16</td> <td>Truncal and limb ataxia</td> <td><em>STUB1</em></td> <td>STIP1 homology and U-box containing protein 1</td> </tr> <tr> <td>SCAR17</td> <td>Childhood-onset gait ataxia, intellectual disability</td> <td><em>CWF19L1</em></td> <td>CWF19-like 1, cell cycle control</td> </tr> <tr> <td>SCAR18</td> <td>Developmental delay, severe gait impairment, oculomotor abnormalities</td> <td><em>GRID2</em></td> <td>Glutamate ionotropic receptor delta type subunit 2</td> </tr> <tr> <td>SCAR19</td> <td>Lichtenstein-Knorr syndrome (severe progressive sensorineural hearing loss and cerebellar ataxia)</td> <td><em>SLC9A1</em></td> <td>Solute carrier family 9 member A1</td> </tr> <tr> <td>SCAR20</td> <td>Ataxia, severe developmental delay, poor/absent speech, coarse facies, cerebellar atrophy</td> <td><em>SNX14</em></td> <td>Sorting nexin 14</td> </tr> <tr> <td>SCAR21</td> <td>Ataxia, liver dysfunction or failure</td> <td><em>SCYL1</em></td> <td>SCY1-like pseudokinase 1</td> </tr> <tr> <td>SCAR22</td> <td>Adult-onset cerebellar ataxia and intellectual disability</td> <td><em>VWA3B</em></td> <td>von Willebrand factor A domain containing 3B</td> </tr> <tr> <td>SCAR23</td> <td>Epilepsy, intellectual disability, gait ataxia</td> <td><em>TDP2</em></td> <td>Tyrosyl-DNA phosphodiesterase 2</td> </tr> <tr> <td>SCAR24</td> <td>Gait instability, speech difficulties, delayed growth in childhood</td> <td><em>UBA5</em></td> <td>Ubiquitin-like modifier activating enzyme 5</td> </tr> <tr> <td>SCAR25</td> <td>Dysmetria, truncal ataxia, developmental delay, cerebellar hypoplasia</td> <td><em>ATG5</em></td> <td>Autophagy related 5</td> </tr> <tr> <td>SCAR26*</td> <td>Dysmetria, dysdiadochokinesis, cerebellar atrophy</td> <td><em>XRCC1</em></td> <td>X-ray repair cross complementing 1</td> </tr> <tr> <td>SCAR27</td> <td>Gait difficulties, dysarthria, lower-limb spasticity, cerebellar atrophy</td> <td><em>GDAP2</em></td> <td>Ganglioside-induced differentiation associated protein 2</td> </tr> <tr> <td>SCAR28</td> <td>Early childhood motor delay, uncoordinated fine movements, dysarthria</td> <td><em>THG1L</em></td> <td>tRNA-histidine guanylyltransferase 1-like</td> </tr> <tr> <td>SCAR29</td> <td>Bayahaka neurodevelopmental disorder (hypotonia, visual impairment, cerebellar ataxia)</td> <td><em>VPS41</em></td> <td>VPS41, HOPS complex subunit</td> </tr> <tr> <td>SCAR30</td> <td>Impaired intellectual development, motor dysfunction, cerebellar ataxia</td> <td><em>PITRM1</em></td> <td>Pitrilysin metallopeptidase 1</td> </tr> <tr> <td>SCAR31</td> <td>Ataxia, hypotonia, tremor, dysarthria</td> <td><em>ATG7</em></td> <td>Autophagy related 7</td> </tr> </tbody></table></div><div class="graphic_footnotes">SCAN: spinocerebellar ataxia with neuropathy; AOA: ataxia with oculomotor apraxia; STIP1: stress-induced phosphoprotein 1; tRNA: transfer ribonucleic acid; VPS41: vacuolar protein sorting-associated protein 41 homolog; HOPS: homotypic fusion and protein sorting.<br/>
* Also categorized as an ataxia syndrome caused by impaired DNA repair mechanisms.</div><div class="graphic_reference">Data from: <a href="https://www.ncbi.nlm.nih.gov/omim" target="_blank">Online Mendelian Inheritance in Man</a>.</div><div id="graphicVersion">Graphic 133268 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
